Inogen(INGN) Prnewswire·2025-01-27 03:17Strategic Partnership and Investment - Yuwell Medical announced a strategic investment and partnership with Inogen, a leading U.S. company in respiratory health, to advance medical device solutions and deepen collaboration [1][3] - Yuwell Medical, through its subsidiary Yuwell (Hong Kong) Holdings Limited, agreed to invest approximately $27.2 million in Inogen, representing 9.9% of Inogen's outstanding common stock [5] Yuwell Medical's Strategic Vision - Yuwell Medical aims to become one of the top three companies in the global home medical health market in the mid-to-long term, focusing on respiratory treatment solutions, diabetes care, and emergency service solutions [2] - The company plans to strengthen its globalization strategy through organizational structure expansion, recruitment of overseas talent, product R&D innovation, and supply chain integration innovation [2] Collaboration Details - Yuwell Medical and Inogen formalized their collaboration by signing a strategic investment and cooperation memorandum, focusing on the respiratory segment [3] - The two companies will collaborate in four areas: international distribution business, trademark licensing and distribution business, joint research and development, and supply chain optimization [6] Company Background and Expertise - Yuwell Medical is recognized as one of the world's largest manufacturers of oxygen concentrators, known for its strong R&D and advanced manufacturing capabilities [4] - Inogen brings extensive experience in portable oxygen concentrator technology, complementing Yuwell's expertise in the respiratory health sector [5] Future Outlook - Yuwell Medical and Inogen aim to enhance their international competitiveness and deliver innovative products that improve lives worldwide through their long-term strategic partnership [7] - Yuwell Medical remains focused on innovation, driving breakthroughs in medical technology, and collaborating with global partners to shape the future of healthcare [7]